Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysis-Reference-Cited by-同舟云学术

Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysis

Published:2021-03-17 Issue:4 Volume:41 Page:705-709
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Taneja Sunil¹^ORCID,Duseja Ajay¹^ORCID,Mehta Manu¹,De Arka¹,Verma Nipun¹^ORCID,Premkumar Madhumita¹,Dhiman Radha K.¹,Singh Virendra¹^ORCID,Singh Mini P.²,Ratho Radha K.²,Ramachandran Raja³,Kumar Vivek³,Kohli Harbir S.³

Affiliation:

1. Department of Hepatology Postgraduate Institute of Medical Education and Research Chandigarh India

2. Department of Virology Postgraduate Institute of Medical Education and Research Chandigarh India

3. Department of Nephrology Postgraduate Institute of Medical Education and Research Chandigarh India

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14685

Reference33 articles.

1. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients

2. Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention

3. Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital

4. Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach

5. Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing hepatitis C management in ESRD: Evaluating efficacy and safety of alternative antiviral regimens;Therapeutic Apheresis and Dialysis;2024-09-14

2. Recompensation of Chronic Hepatitis C–Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program;Gastroenterology;2024-08

3. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

4. Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy;Therapeutic Apheresis and Dialysis;2023-05-22

5. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02